control group:oral probiotic simulant

2 trials

Sponsors

the first affiliated hospital of harbin medical university

Conditions

type 2 diabetes

Unknown Phase

A randomised,double-blind,placebo-controlled trial,to evaluate the effects of LRa05 combined with hypoglycemic agent on glycated hemoglobin and intestinal flora in T2DM patients

Active, not recruitingChiCTR2300073308

the first affiliated hospital of harbin medical universitytype 2 diabetes

Start: 2023-08-01Updated: 2023-07-10

A randomised,double-blind,placebo-controlled trial,to evaluate the effects of BLa80 combined with hypoglycemic agent on glycated hemoglobin and intestinal flora in T2DM patients

Active, not recruitingChiCTR2300073412

the first affiliated hospital of harbin medical universitytype 2 diabetes

Start: 2023-08-01Updated: 2023-07-16